249 related articles for article (PubMed ID: 33466172)
1. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
Lin X; Zou J; Yao K; Li L; Zhong L
Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
Lönnqvist E; Barkoff AM; Mertsola J; He Q
J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
[TBL] [Abstract][Full Text] [Related]
4. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
[TBL] [Abstract][Full Text] [Related]
5. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
Zhang Q; Li M; Wang L; Xin T; He Q
Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
[TBL] [Abstract][Full Text] [Related]
6. Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR.
Wang Z; Han R; Liu Y; Du Q; Liu J; Ma C; Li H; He Q; Yan Y
J Clin Microbiol; 2015 Nov; 53(11):3418-22. PubMed ID: 26224847
[TBL] [Abstract][Full Text] [Related]
7. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
[TBL] [Abstract][Full Text] [Related]
8. Co-infection with two different strains of Bordetella pertussis in an infant.
Cassiday PK; Tobin-D'Angelo M; Watson JR; Wu KH; Park MM; Sanden GN
J Med Microbiol; 2008 Mar; 57(Pt 3):388-391. PubMed ID: 18287306
[TBL] [Abstract][Full Text] [Related]
9. The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Yamaguchi T; Kawasaki Y; Katsukawa C; Kawahara R; Kawatsu K
Jpn J Infect Dis; 2020 Sep; 73(5):361-362. PubMed ID: 32350216
[TBL] [Abstract][Full Text] [Related]
10. The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study.
Wang Z; Luan Y; Du Q; Shu C; Peng X; Wei H; Hou T; Liu Y; Liu X; Li Y
BMC Infect Dis; 2020 Aug; 20(1):615. PubMed ID: 32814558
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility and antigen genotypes of Bordetella pertussis strains isolated from neonates].
Li LJ; Liu Y; Jia J; Yuan L; Shi W; Meng QH; Yao KH
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Mar; 21(3):208-213. PubMed ID: 30907341
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
Li L; Deng J; Ma X; Zhou K; Meng Q; Yuan L; Shi W; Wang Q; Li Y; Yao K
Emerg Infect Dis; 2019 Dec; 25(12):2205-2214. PubMed ID: 31742507
[TBL] [Abstract][Full Text] [Related]
13. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.
Bartkus JM; Juni BA; Ehresmann K; Miller CA; Sanden GN; Cassiday PK; Saubolle M; Lee B; Long J; Harrison AR; Besser JM
J Clin Microbiol; 2003 Mar; 41(3):1167-72. PubMed ID: 12624047
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance.
Fu P; Wang C; Tian H; Kang Z; Zeng M
Pediatr Infect Dis J; 2019 Apr; 38(4):370-376. PubMed ID: 30882726
[TBL] [Abstract][Full Text] [Related]
16. Where macrolide resistance is prevalent.
Li Y; Liu X; Zhang B; He Q; Wang Z
APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
[No Abstract] [Full Text] [Related]
17. Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.
Wu S; Hu Q; Yang C; Zhou H; Chen H; Zhang Y; Jiang M; He Y; Shi X
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):53. PubMed ID: 34407803
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
[TBL] [Abstract][Full Text] [Related]
20. Macrolide-Resistant Bordetella pertussis, Vietnam, 2016-2017.
Kamachi K; Duong HT; Dang AD; Hai T; Do D; Koide K; Otsuka N; Shibayama K; Hoang HTT
Emerg Infect Dis; 2020 Oct; 26(10):2511-2513. PubMed ID: 32946738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
